Clinical Trial Update: Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating intraperitoneal natural killer cells in combination with INCB024360 for recurrent ovarian, fallopian tube, and primary peritoneal can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• INCB024360 (epacadostat)
• Intraperitoneal natural killer cells (natural killer cells)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Ovarian Cancer, Fallopian Tube Carcinoma | Phase 1 | Status: COMPLETED